C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/207, 260/302
C07D 261/08 (2006.01) A61K 31/395 (2006.01) C07D 277/28 (2006.01) C07D 277/30 (2006.01) C07D 307/54 (2006.01) C07D 333/24 (2006.01) C07D 417/04 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2016182
Heterocyclicguanidines at 5HT3 antagonists useful in the treatment of nausea, anxiety, pain, schizophrenia and gastrointestinal disorders. Image wherein said substituent is each methyl, methoxy, chloro, fluoro or bromo; Het is thiazolyl, furyl, thienyl or isox- azolyl; R1 is hydrogen or methyl; R2 and R3 when considered separately are each hydrogen, hydroxyethyl, alkyl having one to six carbon atoms, cycloalkyl having three to six carbon atoms or acetyl; and R2 and R3 when taken together are alkylene having two to three carbon atoms.
Nagel Arthur Adam
Rizzi James Patrick
Rosen Terry Jay
Limited Pfizer
Smart & Biggar
LandOfFree
Heterocyclicguanidines as 5ht- antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclicguanidines as 5ht- antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclicguanidines as 5ht- antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1600478